Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome

ConditionKidney Failure, Acute

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-100

SponsorUniversity Hospital, Bonn

About this trial

Evaluation of non-invasive prognostic parameters in patients developing ACLF and renal failure in patients receiving and not receiving transjugular intrahepatic portosystemic shunt (TIPS). Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.

Eligibility criteria

Qualifiers

All patients with portal hypertension and kidney failure

Disqualifiers

no consent, no kidney failure, no portal hypertension

Trial design

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants

are grouped into 2 trial groups

Sponsors and collaborators

University Hospital, Bonn

Lead sponsor

Source ClinicalTrials.gov